Total Funding
23
56
Total FundingPost-IPO Equity raised
Growth Score 23 in past quarter
1 pts
Heat Score 56 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
132216
Quotient Biodiagnostics develops and manufactures products for use in transfusion diagnostics.
Roland Boyd: CFOPast Role: Accenture, Accounting Professional- Christine Ginocchio: Chief Scientific and Medical Officer
About the Company
Quotient Biodiagnostics is focused on providing high quality, high value immunohematology products to hospitals and blood banks in the US. Through its wholly-owned subsidiary, Alba Bioscience, Quotient offers more than 30 years of research, development and manufacturing of transfusion diagnostics products that traditionally have been sold worldwide
either directly or by other major transfusion companies.

